• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Replacement Heart Valves

LivaNova slides despite Street-beating Q4

February 24, 2021 By Sean Whooley Leave a Comment

LivaNova (NSDQ:LIVN) shares took a dip this morning despite fourth-quarter results that topped the consensus forecast. The London-based company posted losses of $279.8 million, or -$5.75 per share, on sales of $269.6 million for the three months ended Dec. 31, 2020, for a 95.4% bottom-line slide deeper into the red on a sales decline of -6.3%. […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, Replacement Heart Valves, Structural Heart, Wall Street Beat Tagged With: LivaNova

Edwards touts 5-year aortic valve trial results

February 1, 2021 By Sean Whooley

Edwards Lifesciences (NYSE:EW) announced data showing favorable safety and hemodynamic performance from its Resilia tissue platform. Data from Edwards’ Commence clinical trial demonstrated that its bioprosthetic surgical aortic valve with the novel Resilia tissue aortic valve platform produced favorable results across a median of five years follow-up, according to a news release. Commence is a prospective, […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Replacement Heart Valves, Structural Heart Tagged With: Edwards Lifesciences

Abbott’s MitraClip receives boost as CMS expands coverage for TMVR

January 20, 2021 By Sean Whooley

Abbott (NYSE:ABT) announced today that CMS revised its coverage for TMVR, opening up new possibilities for its MitraClip device. The CMS National Coverage Determination (NCD) expands coverage for transcatheter mitral valve repair (TMVR) to include patients with secondary (or functional) mitral regurgitation (MR) resulting from heart failure. According to an Abbott news release, the CMS decision […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Medicare, Replacement Heart Valves, Structural Heart Tagged With: Abbott, Centers for Medicare and Medicaid Services (CMS), TMVR

These medtech stocks performed the best in 2020

January 15, 2021 By Sean Whooley

While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while […]

Filed Under: 510(k), Big Data, Business/Financial News, Cardiac Implants, Cardiovascular, Diabetes, Diagnostics, Drug-Device Combinations, Electronic Medical Records (EMR), Featured, Food & Drug Administration (FDA), Funding Roundup, Genomics/Molecular Diagnostics, Health Technology, MassDevice Earnings Roundup, Mergers & Acquisitions, Orthopedics, Regulatory/Compliance, Replacement Heart Valves, Research & Development, Respiratory, Robotics, Software / IT, Structural Heart, Surgical, Wall Street Beat Tagged With: Abbott, Abiomed, coronavirus, COVID-19, Dexcom, Edwards Lifesciences, Hologic, Intuitive Surgical, iRhythm Technologies Inc., Masimo, ResMed, ResMed Inc., Stryker

CorWave raises $40m in funding for breakthrough heart pump

January 6, 2021 By Sean Whooley

CorWave announced today that it raised $40 million from a mix of returning and new investors for its wave membrane heart pump. Clichy, France-based CorWave received funding — from three new investors joining its returning investors — which is earmarked for its implantable left ventricular assist device (LVAD) which uses its breakthrough wave membrane pump […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Funding Roundup, Replacement Heart Valves, Structural Heart Tagged With: CorWave

4C Medical Technologies completes $10M financing

December 28, 2020 By Sean Whooley

4C Medical Technologies announced that it completed an over-subscribed convertible note financing worth $10 million in gross proceeds. Minneapolis-based 4C Medical Technologies said in a news release that an unnamed China-based venture firm led the financing round. The company plans to use the net proceeds from the financing to fund the continued development of its […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Funding Roundup, Replacement Heart Valves, Structural Heart Tagged With: 4cmedical

TricValve transcatheter bicaval valves system wins FDA breakthrough designation

December 28, 2020 By Sean Whooley

P+F Products + Features GmbH announced that it received FDA breakthrough device designation for its TricValve system. Vienna-based P+F received the breakthrough nod earlier this month for the transcatheter bicval valves system, comprised of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux, according to a news […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Replacement Heart Valves, Structural Heart Tagged With: FDA, P+F Products + Features GmbH

Edwards treats first patient in mitral valve disease trial

December 21, 2020 By Sean Whooley

Edwards Lifesciences (NYSE:EW) announced today that it treated the first patient in a clinical trial for its Harpoon valve repair system. Harpoon is an investigational beating heart mitral valve repair system designed with a less invasive technique than open heart surgery for treating severe degenerative mitral valve regurgitation, according to a news release. Irvine, Calif.-based Edwards […]

Filed Under: Cardiovascular, Clinical Trials, Featured, Replacement Heart Valves, Structural Heart Tagged With: Edwards Lifesciences

Health Canada gives Edwards’ Sapien 3 TAVR expanded use nod

December 18, 2020 By Nancy Crotti

Edwards Lifesciences (NYSE:EW) today announced that Health Canada has approved the expanded use of the company’s Sapien 3 and Sapien 3 Ultra transcatheter heart valves to treat patients diagnosed with severe symptomatic aortic stenosis who are at low risk for open-heart surgery. The Sapien 3 valves are the first transcatheter aortic valve replacement (TAVR) systems to […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Featured, Regulatory/Compliance, Replacement Heart Valves Tagged With: Edwards Lifesciences, Health Canada

Boston Sci among UBS analysts’ top stock picks for 2021

December 17, 2020 By Sean Whooley

UBS Investment Bank listed Boston Scientific (NYSE:BSX) among its 21 most compelling stock investment selections for 2021. Marlborough, Mass.-based Boston Scientific was the only medical device company on a list that featured companies such as Amazon, Morgan Stanley and Southwest Airlines. Additionally, Vertex Pharmaceuticals represented the biotech space, while Acadia Healthcare registered for healthcare facilities. UBS […]

Filed Under: Business/Financial News, Cardiovascular, Featured, MassDevice Earnings Roundup, Replacement Heart Valves, Structural Heart, Wall Street Beat Tagged With: Boston Scientific, tavr, UBS

MedTech 100 roundup: Stocks stay near last week’s peak

December 14, 2020 By Sean Whooley

The medtech industry is poised for a big week with the U.S. rollout of the COVID-19 vaccine and stocks remain high from previous peaks. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 100.03 (Dec. 11), marking a minor 0.7% uptick from the 100.75 points […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Legal News, MassDevice Earnings Roundup, Pharmaceutical, Replacement Heart Valves, Research & Development, Structural Heart, Wall Street Beat Tagged With: Abbott, BioNTech, coronavirus, COVID-19, Edwards Lifesciences, MedTech 100 Index, Medtronic, Pfizer

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 68
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS